Cargando…

Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey

INTRODUCTION: Effective communication between patients with psoriatic arthritis (PsA) and their physicians is important for optimizing treatment outcomes. We assessed the quality of patient–physician communication in terms of awareness and impact of PsA symptoms, their levels of satisfaction, and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coates, Laura C., Azevedo, Valderilio F., Cappelleri, Joseph C., Moser, Jade, Eder, Lihi, Richette, Pascal, Weng, Meng-Yu, Silva, Ruben Queiro, Garg, Amit, Majjhoo, Amar, Griffiths, Christopher E. M., Young, Pamela, Howland, Samantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572306/ https://www.ncbi.nlm.nih.gov/pubmed/34570345 http://dx.doi.org/10.1007/s40744-021-00367-z

Ejemplares similares

Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey
por: Richette, Pascal, et al.
Publicado: (2022)

Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey
por: Lim, Irwin, et al.
Publicado: (2021)

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
por: Coates, L. C., et al.
Publicado: (2020)

Risk factors and predictors of psoriatic arthritis in patients with psoriasis
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2013)

Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findings
por: Diaz, Pamela, et al.
Publicado: (2022)

Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
por: Karmacharya, Paras, et al.
Publicado: (2021)

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models
por: Queiro, Rubén
Publicado: (2022)

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
por: de Vlam, Kurt, et al.
Publicado: (2021)

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis
por: Queiro, Rubén, et al.
Publicado: (2021)

Identifying and Quantifying the Role of Inflammation in Pain Reduction for Patients With Psoriatic Arthritis Treated With Tofacitinib: A Mediation Analysis
por: de Vlam, Kurt, et al.
Publicado: (2022)

Obesity in psoriatic arthritis: Comparative prevalence and associated factors
por: Queiro, Rubén, et al.
Publicado: (2019)

The association between sonographic enthesitis and radiographic damage in psoriatic arthritis
por: Polachek, Ari, et al.
Publicado: (2017)

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries
por: Lucasson, Florian, et al.
Publicado: (2022)

Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis
por: Polachek, Ari, et al.
Publicado: (2019)

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease
por: Queiro, Rubén, et al.
Publicado: (2021)

The epidemiology of psoriatic arthritis in Israel – a population-based study
por: Eder, Lihi, et al.
Publicado: (2018)

Gene Variant in the NF-κB Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease
por: Coto-Segura, Pablo, et al.
Publicado: (2019)

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
por: Orbai, Ana-Maria, et al.
Publicado: (2017)

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
por: Mease, Philip J., et al.
Publicado: (2020)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
por: Queiro, Rubén, et al.
Publicado: (2022)

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status
por: Queiro, Rubén, et al.
Publicado: (2022)

Influenza H1N1 infection in a patient with psoriatic arthritis in treatment with Adalimumab: a case report
por: Serrato, Varlei A., et al.
Publicado: (2010)

HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis
por: Queiro, Ruben, et al.
Publicado: (2006)

Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
por: Braña, Ignacio, et al.
Publicado: (2023)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study
por: Queiro, Ruben, et al.
Publicado: (2020)

Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis
por: Helliwell, Philip, et al.
Publicado: (2014)

Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain
por: García, Emilio Ignacio, et al.
Publicado: (2020)

The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review
por: Cañete, Juan D., et al.
Publicado: (2020)

Defining imaging sub-phenotypes of psoriatic arthritis: integrative analysis of imaging data and gene expression in a PsA patient cohort
por: Eder, Lihi, et al.
Publicado: (2022)

The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis
por: Queiro, Rubén, et al.
Publicado: (2014)

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
por: Queiro, Rubén, et al.
Publicado: (2017)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
por: Gladman, Dafna D., et al.
Publicado: (2022)

Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
por: Kivitz, Alan J., et al.
Publicado: (2021)

Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States
por: Bungey, George, et al.
Publicado: (2020)

Psoriatic arthritis: prospects for the future
por: Hackett, Simon, et al.
Publicado: (2022)

Treatment guidelines in psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib
por: Coates, Laura C., et al.
Publicado: (2021)

Outcome measures in psoriatic arthritis: Where next?
por: Hackett, Simon, et al.
Publicado: (2022)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_446dga2nvhta0obbm0b7d8obu1